179 related articles for article (PubMed ID: 25173047)
1. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047
[TBL] [Abstract][Full Text] [Related]
2. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
[TBL] [Abstract][Full Text] [Related]
3. Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery.
Shuey MM; Billings FT; Wei S; Milne GL; Nian H; Yu C; Brown NJ
PLoS One; 2017; 12(5):e0175292. PubMed ID: 28552948
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans.
Lee CR; Pretorius M; Schuck RN; Burch LH; Bartlett J; Williams SM; Zeldin DC; Brown NJ
Hypertension; 2011 Jan; 57(1):116-22. PubMed ID: 21098312
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.
Luria A; Bettaieb A; Xi Y; Shieh GJ; Liu HC; Inoue H; Tsai HJ; Imig JD; Haj FG; Hammock BD
Proc Natl Acad Sci U S A; 2011 May; 108(22):9038-43. PubMed ID: 21571638
[TBL] [Abstract][Full Text] [Related]
7. Epoxyeicosatrienoic Acids are Mediated by EPHX2 Variants and may be a Predictor of Early Neurological Deterioration in Acute Minor Ischemic Stroke.
Yi X; Lin J; Li J; Zhou Q; Han Z
J Atheroscler Thromb; 2017 Dec; 24(12):1258-1266. PubMed ID: 28835580
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
9. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.
Zhu X; Li Y; Yu T; Li S; Chen M
Gene; 2022 May; 822():146340. PubMed ID: 35183688
[TBL] [Abstract][Full Text] [Related]
10. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
[TBL] [Abstract][Full Text] [Related]
11. Epoxyeicosatrienoic acids and glucose homeostasis in mice and men.
Luther JM; Brown NJ
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():2-7. PubMed ID: 27448715
[TBL] [Abstract][Full Text] [Related]
12. [Enhanced expression of EPHX2 gene in the kidney of the hypertensive ISIAH rats].
Abramova TO; Redina OE; Smolenskaia SE; Markel AL
Mol Biol (Mosk); 2013; 47(6):942-8. PubMed ID: 25509856
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.
Lee CR; North KE; Bray MS; Fornage M; Seubert JM; Newman JW; Hammock BD; Couper DJ; Heiss G; Zeldin DC
Hum Mol Genet; 2006 May; 15(10):1640-9. PubMed ID: 16595607
[TBL] [Abstract][Full Text] [Related]
14. Missense Genetic Polymorphisms of Microsomal (
Can Demirdöğen B; Miçooğulları Y; Türkanoğlu Özçelik A; Adalı O
Neuropsychiatr Dis Treat; 2020; 16():3251-3265. PubMed ID: 33994786
[TBL] [Abstract][Full Text] [Related]
15. Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.
Strauss KI; Gruzdev A; Zeldin DC
Prostaglandins Other Lipid Mediat; 2013; 104-105():18-24. PubMed ID: 22922090
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in human soluble epoxide hydrolase.
Przybyla-Zawislak BD; Srivastava PK; Vazquez-Matias J; Mohrenweiser HW; Maxwell JE; Hammock BD; Bradbury JA; Enayetallah AE; Zeldin DC; Grant DF
Mol Pharmacol; 2003 Aug; 64(2):482-90. PubMed ID: 12869654
[TBL] [Abstract][Full Text] [Related]
17. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.
Luria A; Weldon SM; Kabcenell AK; Ingraham RH; Matera D; Jiang H; Gill R; Morisseau C; Newman JW; Hammock BD
J Biol Chem; 2007 Feb; 282(5):2891-8. PubMed ID: 17135253
[TBL] [Abstract][Full Text] [Related]
18. Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease.
Lee J; Dahl M; Grande P; Tybjaerg-Hansen A; Nordestgaard BG
Stroke; 2010 Jan; 41(1):27-33. PubMed ID: 19940276
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of soluble epoxide hydrolase reduces post-ischemic recovery of cardiac contractile function.
Edin ML; Gruzdev A; Bradbury JA; Graves JP; Muse GW; Goulding DR; Lih FB; DeGraff LM; Zeldin DC
Biochem Pharmacol; 2024 Apr; ():116237. PubMed ID: 38679211
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
